Subtype
Urinary Tract Neoplasm
CI-CAN-00001627Explore in graph →
Non-malignant558 active trials14 approved drugs29 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001627Explore in graph →
Clinical trials
2,186 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07510685 | Closed-System Bladder Irrigation to Reduce Urinary Tract Infections After Endoscopic Urologic Surgery (IRIS Trial)(IRIS) | completed | N/A | 240 | University of PisaOTHER | 1 | Apr 3, 2026 | clinicaltrials |
| NCT04822350 | A NON-INTERVENTIONAL STUDY ON AVELUMAB USE IN PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CARCINOMA(AVENANCE) | completed | — | 596 | PfizerINDUSTRY | 1 | Apr 2, 2026 |
| clinicaltrials |
| NCT07505615 | A Phase I-II Study of Novel Oncolytic Virus VG161 Via Intravesical Instillation for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer(VG-INFUSE Tria) | completed | Phase 1 / Phase 2 | 20 | Ding-Wei YeOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT05226117 | Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer | completed | Phase 2 | 44 | IRCCS San RaffaeleOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT02690558 | Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy | completed | Phase 2 | 39 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT04055311 | Recovery Support for Bladder Cancer Patients and Caregivers | completed | N/A | 174 | Northwell HealthOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT06072027 | Evaluation of VISIOCYT Bladder Cytology in Real Life(VISIOCYT2) | completed | — | 701 | Institut Paoli-CalmettesOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT07481123 | COMPARISON OF OBTURATOR NERVE BLOCK TECHNIQUES IN TURBT | completed | N/A | 60 | Yavuz SaygılıOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT01616875 | Bristol Bladder Trial | completed | Phase 2 | 28 | University Hospitals Bristol and Weston NHS Foundation TrustOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT01104350 | Image-Guided Radiation Therapy for Bladder-Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy | completed | Phase 1 | 19 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT03348969 | Neoadjuvant Short-term Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in NMIBC(NICSA) | completed | Phase 4 | 120 | Jørgen Bjerggaard JensenOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT06281691 | GreenBladder - Early Detection of Bladder Cancer in Residents in Greenland Using a Urinary Marker and a Mobile Cystoscopy Unit | completed | — | 127 | Jørgen Bjerggaard JensenOTHER | 2 | Mar 3, 2026 | clinicaltrials |
| NCT07445451 | Magnesium vs. Dexmedetomidine in TURBT Under Spinal Anesthesia(TURBT) | completed | N/A | 93 | Dr. Lutfi Kirdar Kartal Training and Research HospitalOTHER_GOV | 1 | Mar 3, 2026 | clinicaltrials |
| NCT04321707 | Complete Local Response to Neoadjuvant Chemotherapy in Patients With Muscle Invasive Bladder Cancer Evaluated by 15O-H2O PET/MR(MAINTAIN) | completed | N/A | 13 | Jørgen Bjerggaard JensenOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT04610671 | Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC | completed | Phase 1 | 21 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT04172675 | A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) | completed | Phase 2 | 107 | Janssen Research & Development, LLCINDUSTRY | 17 | Feb 24, 2026 | clinicaltrials |
| NCT02989064 | MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers | completed | Phase 1 | 10 | AdaptimmuneINDUSTRY | 3 | Feb 4, 2026 | clinicaltrials |
| NCT04701918 | Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma | completed | Phase 2 | 9 | Massachusetts General HospitalOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT07347132 | Comparison of Pathological Outcome and Recurrence Rate Between En Bloc and Conventional Transurethral Resection of Bladder Tumor | completed | N/A | 116 | Lahore General HospitalOTHER_GOV | 1 | Jan 16, 2026 | clinicaltrials |
| NCT01810757 | Study of Weekly Radiotherapy for Bladder Cancer(HYBRID) | completed | N/A | 65 | Institute of Cancer Research, United KingdomOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT05375903 | A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) | completed | Phase 1 | 51 | UroGen Pharma Ltd.INDUSTRY | 3 | Jan 14, 2026 | clinicaltrials |
| NCT03474107 | A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301) | completed | Phase 3 | 608 | Astellas Pharma Global Development, Inc.INDUSTRY | 19 | Jan 9, 2026 | clinicaltrials |
| NCT04897763 | Assessment of Safety, Tolerability, Radiation Dosimetry, Imaging Properties of 89Zr-girentuximab in Patients With NMIBC(PERTINENCE) | completed | Early Phase 1 | 6 | Institut Cancerologie de l'OuestOTHER | 1 | Jan 7, 2026 | clinicaltrials |
| NCT04553939 | Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer | completed | Phase 2 | 50 | Henan Cancer HospitalOTHER_GOV | 1 | Jan 2, 2026 | clinicaltrials |
| NCT02276924 | Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract Tumors(UROVISIO) | completed | N/A | 29 | Lille Catholic UniversityOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT04157985 | Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors | completed | Phase 3 | 161 | Dan ZandbergOTHER | 1 | Dec 11, 2025 | clinicaltrials |
| NCT04566029 | Evolution of Proteomic Profiles of Intestinal Microbiota in Patients With Locally Advanced or Metastatic Urothelial Carcinomas(AMI) | completed | — | 40 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Dec 10, 2025 | clinicaltrials |
| NCT07259798 | Histopathological Findings in En-Bloc vs Conventional Transurethral Resection of Bladder Tumors. | completed | N/A | 50 | Ain Shams UniversityOTHER | 1 | Dec 10, 2025 | clinicaltrials |
| NCT04501913 | Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes | completed | — | 22 | City of Hope Medical CenterOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT03575013 | A Combination of Avelumab and Taxane (AVETAX) for Urothelial Cancer | completed | Phase 1 | 21 | Yousef ZakhariaOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT05630131 | ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy | completed | — | 1 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Nov 28, 2025 | clinicaltrials |
| NCT07251946 | Development of Multiphasic CT-based Delta-Radiomics Model for Predicting Postoperative Recurrence Risk in Bladder Cancer | completed | — | 316 | Lian YangOTHER | 1 | Nov 26, 2025 | clinicaltrials |
| NCT04533672 | Multiparametric Magnetic Resonance Imaging (MRI) to Improve Bladder Cancer Staging and Treatment Decision-making(SBCT) | completed | N/A | 186 | University of ZurichOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT06397040 | The Use of Remote Monitoring to Improve Patient-Reported Outcomes and Readmission Rates Following Radical Cystectomy(WATCH) | completed | N/A | 38 | University of PittsburghOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT01812369 | Perioperative Chemotherapy for Patients With Locally Advanced Bladder Cancer(VESPER) | completed | Phase 3 | 500 | University Hospital, RouenOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT03914794 | A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors | completed | Phase 2 | 30 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 3, 2025 | clinicaltrials |
| NCT07201441 | The Impact of Intelligent Nursing Based on Health Cloud Platform on Active Health Management of Urostomy Patients | completed | N/A | 42 | Sir Run Run Shaw HospitalOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT06157814 | Mobile Ostomates Resources for Patients and Caregivers(MORE) | completed | N/A | 26 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Sep 25, 2025 | clinicaltrials |
| NCT04053101 | Role of FDG-PET CT in the Management of Muscle Invasive Bladder Cancer(TEP-Vessie) | completed | — | 130 | Institut BergoniéOTHER | 1 | Sep 18, 2025 | clinicaltrials |
| NCT04383743 | Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer | completed | Phase 2 | 17 | University of WashingtonOTHER | 1 | Sep 18, 2025 | clinicaltrials |
| NCT04344795 | Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors | completed | Phase 1 | 89 | Tempest TherapeuticsINDUSTRY | 1 | Sep 12, 2025 | clinicaltrials |
| NCT04892342 | Study of ESG401 in Adults With Solid Tumors | completed | Phase 1 / Phase 2 | 156 | Shanghai Escugen Biotechnology Co., LtdINDUSTRY | 1 | Sep 12, 2025 | clinicaltrials |
| NCT04534075 | Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial(FIDURA) | completed | Phase 3 | 354 | Sahlgrenska University HospitalOTHER | 1 | Sep 8, 2025 | clinicaltrials |
| NCT06582849 | Enhanced Assistance During Radiotherapy for Unmet Essential Needs(EARN) | completed | N/A | 33 | Washington University School of MedicineOTHER | 1 | Aug 26, 2025 | clinicaltrials |
| NCT03232541 | The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting | completed | N/A | 198 | Västernorrland County Council, SwedenOTHER_GOV | 1 | Aug 24, 2025 | clinicaltrials |
| NCT03039413 | Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy | completed | Early Phase 1 | 20 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Aug 22, 2025 | clinicaltrials |
| NCT05259696 | Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)(GLIMMER-01) | completed | Phase 1 / Phase 2 | 69 | Palleon Pharmaceuticals, Inc.INDUSTRY | 1 | Aug 20, 2025 | clinicaltrials |
| NCT05111639 | Decision Making for Urinary Diversion in Patients With Bladder Cancer | completed | — | 52 | University of Colorado, DenverOTHER | 1 | Aug 14, 2025 | clinicaltrials |
| NCT02475213 | Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer | completed | Phase 1 | 146 | MacroGenicsINDUSTRY | 1 | Aug 11, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Apr 3, 2026source: clinicaltrials